Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT05665608

Prevention Of Sudden Cardiac Death After Myocardial Infarction by Defibrillator Implantation

Led by Charite University, Berlin, Germany · Updated on 2026-04-01

3595

Participants Needed

86

Research Sites

210 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Patients who have survived a myocardial infarction (MI) are at increased risk for sudden cardiac death (SCD) caused by ventricular tachycardia and ventricular fibrillation. A severely reduced left ventricular ejection fraction (LVEF) as a rough overall measure of impaired heart function after MI was shown to indicate a higher risk for SCD. Based on this observation, two landmark randomised trials, MADIT II and SCD-HeFT, were conducted between end of the 1990s and early 2000s. These trials compared the survival of patients with severely reduced LVEF who received an implantable cardioverter-defibrillator with the survival of patients being on medical therapy alone. They reported a significantly better survival of patients in the defibrillator arm and led to international guideline recommendations for routine implantation of defibrillators in survivors of MI with severely impaired LVEF as a means for primary prevention of SCD. Since then, the management of these patients has changed dramatically with the advent of a series of novel drug classes that reduce not only mortality but specifically SCD leading to a substantial decrease of the sudden death rates as well as of the rates of appropriate defibrillator therapies implanted for primary prevention of SCD. At the same time, the complication rates associated with the defibrilllator therapy remain significant without obvious decrease. Thus, the risk-benefit of routine defibrillator implantation for primary prevention of SCD in patients with severely reduced LVEF has substantially changed since the conduction of the landmark trials that established this therapy. Due to the inherent risks and considerable costs of the defibrillator, a novel randomised adequately powered assessment of the potential benefit or harm of the defibrillator in survivors of MI with reduced LVEF under contemporary optimal medical treatment (OMT) appears imperative. OBJECTIVE: To demonstrate that in post-MI patients with symptomatic heart failure who receive OMT for this condition, and with reduced LVEF ≤ 35%, OMT without ICD implantation (index group) is not inferior to OMT with ICD implantation (control group) with respect to all-cause mortality.

CONDITIONS

Official Title

Prevention Of Sudden Cardiac Death After Myocardial Infarction by Defibrillator Implantation

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 18 years or older
  • No previous implantation of any pacemaker or defibrillator
  • Documented history of myocardial infarction (STEMI or NSTEMI) at least 3 months before enrollment
  • Symptomatic heart failure with New York Heart Association (NYHA) class II or III
  • On optimal medical therapy for at least 3 months before enrollment
  • Left ventricular ejection fraction (LVEF) 35% or less measured at least 3 months after myocardial infarction
  • Signed informed consent
Not Eligible

You will not qualify if you...

  • Indication for ICD implantation for secondary prevention of sudden cardiac death or ventricular tachycardia (class I or IIa)
  • Ventricular tachycardia induced by electrophysiologic study
  • Unexplained fainting (syncope) suspected to be caused by ventricular arrhythmia
  • Indication for cardiac resynchronization therapy (class I or IIa)
  • Likely violation of ICD device instructions for use (applicable to control group only)
  • Acute coronary syndrome, coronary angioplasty, or bypass surgery within 6 weeks before enrollment
  • Cardiac valve surgery or intervention within 6 weeks before enrollment
  • On waiting list for heart transplantation
  • Any disease limiting life expectancy to less than 1 year
  • Participation in another randomized clinical trial with active study treatment at enrollment
  • Previous participation in this trial (PROFID EHRA)

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 86 locations

1

Landeskrankenhaus Feldkirch

Feldkirch, Austria, 6800

Actively Recruiting

2

LKH Universitätsklinikum Graz

Graz, Austria, 8036

Actively Recruiting

3

Tirol Kliniken - Universitätsklinik Innsbruck

Innsbruck, Austria, 6020

Actively Recruiting

4

Klinikum Klagenfurt am Wörthersee

Klagenfurt, Austria, 9020

Actively Recruiting

5

Ordensklinikum Linz GmbH Elisabethinen

Linz, Austria, 4020

Actively Recruiting

6

Landeskrankenhaus Salzburg - Universitätsklinikum der PMU

Salzburg, Austria, 5020

Actively Recruiting

7

Universitätsklinikum St. Pölten

Sankt Pölten, Austria, 3100

Actively Recruiting

8

Klinikum Wels-Grieskirchen GmbH

Wels, Austria, 4600

Actively Recruiting

9

Universitätsklinikum Wiener Neustadt

Wiener Neustadt, Austria, 2700

Actively Recruiting

10

OLV Ziekenhuis Campus Aalst

Aalst, Belgium, 9300

Actively Recruiting

11

AZ Sint-Jan Brugge-Campus Sint-Jan

Bruges, Belgium, 8000

Actively Recruiting

12

Centre hospitaliser régional (CHR) de la Citadelle

Liège, Belgium, 4000

Actively Recruiting

13

Centre Hospitalier Universitaire CHU UCL Namur - Site Godinne

Yvoir, Belgium, 5530

Actively Recruiting

14

Fakultní Nemocnice Olomouc

Olomouc, Czechia, 779 00

Terminated

15

Všeobecná Fakultní Nemocnice v Praze

Prague, Czechia, 128 08

Actively Recruiting

16

Institut Klinické a Experimentální Medicíny

Prague, Czechia, 140 21

Actively Recruiting

17

Masaryk Hospital

Ústí nad Labem, Czechia, 400 11

Actively Recruiting

18

Aarhus University Hospital I

Aarhus, Denmark, 8200

Actively Recruiting

19

CHU Amiens Picardie

Amiens, France, 80054

Actively Recruiting

20

Hôpital de la Cavale Blanche-CHU BREST

Brest, France, 29609

Actively Recruiting

21

CHU Henri Mondor

Créteil, France, 94010

Actively Recruiting

22

University Hospital Grenoble-Alpes

Grenoble, France, 38700

Actively Recruiting

23

Européen Georges Pompidou Hospital Paris

Paris, France, 75015

Actively Recruiting

24

Hôpital Bichat Claude Bernard

Paris, France, 75018

Actively Recruiting

25

Chu de Rennes

Rennes, France, 35000

Actively Recruiting

26

Centre Cardiologique du Nord

Saint-Denis, France, 93200

Actively Recruiting

27

University Hospital Rangueil Toulouse

Toulouse, France, 31059

Actively Recruiting

28

Clinique Pasteur

Toulouse, France, 31076

Actively Recruiting

29

St. Marien-Krankenhaus - Klinikum Westmünsterland

Ahaus, Germany, 48683

Withdrawn

30

Helios Klinikum Aue

Aue, Germany, 08280

Actively Recruiting

31

Kerckhoff-Klinik Bad Nauheim

Bad Nauheim, Germany, 61231

Actively Recruiting

32

Herz- und Diabeteszentrum NRW Universitätsklinik der Ruhr-Universität Bochum

Bad Oeynhausen, Germany, 32545

Actively Recruiting

33

Segeberger Kliniken Gmbh

Bad Segeberg, Germany, 23795

Actively Recruiting

34

Charité - Universitätsmedizin Berlin (CCM)

Berlin, Germany, 10117

Actively Recruiting

35

Sana Klinikum Lichtenberg

Berlin, Germany, 10365

Actively Recruiting

36

Charité - Universitätsmedizin Berlin (CBF)

Berlin, Germany, 12203

Actively Recruiting

37

BG Klinikum Unfallkrankenhaus Berlin

Berlin, Germany, 12683

Actively Recruiting

38

Charité - Universitätsmedizin Berlin (CVK)

Berlin, Germany, 13353

Actively Recruiting

39

Vivantes Humboldt Klinikum

Berlin, Germany, 13509

Withdrawn

40

Klinikum Bielefeld

Bielefeld, Germany, 33604

Actively Recruiting

41

REGIOMED Klinikum Coburg

Coburg, Germany, 96450

Actively Recruiting

42

Carl-Thiem-Klinikum

Cottbus, Germany, 03048

Actively Recruiting

43

Städtisches Klinikum Dresden

Dresden, Germany, 01067

Actively Recruiting

44

Technische Universität Dresden - Herzzentrum Dresden

Dresden, Germany, 01307

Actively Recruiting

45

Elisabeth-Krankenhaus Essen

Essen, Germany, 45138

Actively Recruiting

46

Georg-August-Universität Göttingen - Universitätsmedizin Göttingen

Göttingen, Germany, 37075

Actively Recruiting

47

Universitätsmedizin Greifswald

Greifswald, Germany, 17475

Actively Recruiting

48

Klinikum Gütersloh

Gütersloh, Germany, 33332

Actively Recruiting

49

Asklepios Kliniken Hamburg

Hamburg, Germany, 20099

Actively Recruiting

50

Asklepios Klinikum Harburg

Hamburg, Germany, 21075

Actively Recruiting

51

Albertinen Herz- und Gefäßzentrum

Hamburg, Germany, 22457

Actively Recruiting

52

Universitätsklinikum Jena

Jena, Germany, 07747

Actively Recruiting

53

Westpfalz-Klinikum GmbH

Kaiserslautern, Germany, 67655

Actively Recruiting

54

Städtisches Klinikum Karlsruhe

Karlsruhe, Germany, 76133

Actively Recruiting

55

B.Braun Ambulantes Herzzentrum Kassel

Kassel, Germany, 34121

Actively Recruiting

56

Asklepios Kliniken Langen

Langen, Germany, 63225

Actively Recruiting

57

Universitätsklinikum Leipzig

Leipzig, Germany, 04103

Actively Recruiting

58

Klinikum St. Georg

Leipzig, Germany, 04129

Actively Recruiting

59

Herzzentrum Leipzig

Leipzig, Germany, 04289

Actively Recruiting

60

Universitätsklinikum Schleswig-Holstein

Lübeck, Germany, 23538

Actively Recruiting

61

Johannes Wesling Klinikum

Minden, Germany, 32429

Actively Recruiting

62

Klinikum der Ludwig-Maximilians-Universität München (LMU Klinikum)

München, Germany, 81377

Actively Recruiting

63

FEK - Friedrich-Ebert-Krankenhaus Neumünster

Neumünster, Germany, 24534

Actively Recruiting

64

Klinik Rothenburg ANregiomed

Rothenburg upon Tauber, Germany, 91541

Actively Recruiting

65

Helios Universitätsklinikum Wuppertal

Wuppertal, Germany, 42117

Actively Recruiting

66

Semmelweis University

Budapest, Hungary, 1085

Actively Recruiting

67

Rambam Health Care Campus

Haifa, Israel, 3109601

Actively Recruiting

68

Le Centre Hospitalier Universitaire de Martinique

Fort-de-France Cedex, Martinique, 97261

Actively Recruiting

69

Amsterdam UMC

Amsterdam, Netherlands, 1105

Actively Recruiting

70

Stichting Catharina Ziekenhuis

Eindhoven, Netherlands, 5623

Actively Recruiting

71

Medisch Spectrum Twente

Enschede, Netherlands, 7512 KZ

Actively Recruiting

72

Universitair Medisch Center Groningen

Groningen, Netherlands, 9700

Actively Recruiting

73

Maastricht University Medical Center

Maastricht, Netherlands, 6229

Actively Recruiting

74

Kliniczny Szpital Wojewódzki Nr 2 im.Św.Jadwigi Królowej w Rzeszowie

Rzeszów, Poland, 35-301

Actively Recruiting

75

Wojskowy Instytut Medyczny

Warsaw, Poland, 04-141

Actively Recruiting

76

Śląskie Centrum Chorób Serca w Zabrzu

Zabrze, Poland, 41-800

Actively Recruiting

77

Hospital General Universitario de Alicante

Alicante, Spain, 03010

Actively Recruiting

78

Instituto de Investigación Hospital 12 de Octubre

Madrid, Spain, 28041

Actively Recruiting

79

La Paz University Hospital

Madrid, Spain, 28046

Actively Recruiting

80

Hospital Universitario Virgen de la Arrixaca

Murcia, Spain, 30120

Actively Recruiting

81

Calderdale Royal Hospital

Halifax, United Kingdom, HX3 0PW

Actively Recruiting

82

The Leeds Teaching Hospitals NHS Trust - St James's University Hospital

Leeds, United Kingdom, LS9 7TF

Actively Recruiting

83

Queen Elizabeth The Queen Mother Hospital Margate

Margate, United Kingdom, CT9 4AN

Actively Recruiting

84

George Eliot Hospital

Nuneaton, United Kingdom, CV10 7DJ

Actively Recruiting

85

Salisbury District Hospital

Salisbury, United Kingdom, SP2 8BJ

Actively Recruiting

86

University Hospital of North Tees

Stockton-on-Tees, United Kingdom, TS19 8PE

Actively Recruiting

Loading map...

Research Team

G

Gerhard Hindricks, Prof

CONTACT

N

Nikolaos Dagres, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

PREVENTION

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Prevention Of Sudden Cardiac Death After Myocardial Infarction by Defibrillator Implantation | DecenTrialz